How HIV Is Prevented Today, and How Common It Is in the UK

A nurse in a busy emergency department once described the moment a routine blood panel came back positive for a patient who had come in with a sprained wrist. No symptoms, no sense of being at risk, a life quietly rearranged by a test that ran automatically because the hospital screens everyone. That story captures where HIV sits in 2020s Britain: less visible than ever, still present, and now more often found by systems than by illness.

Forty years ago the conversation was about fear. Today it is about logistics. Which pill, which test, which window of hours after an exposure still counts. The science has moved far faster than public understanding, and a lot of people are still working from a mental map drawn in the 1990s.

This article redraws that map. It explains what actually needs to happen for HIV to move from one body to another, how many people in the UK are living with it, and the handful of measures that, used together, have brought the country within reach of ending new transmissions.

What actually needs to happen for HIV to pass from one person to another?

HIV is a fragile virus with a narrow set of routes into the body. It travels in five body fluids: blood, semen, pre-seminal fluid, vaginal and rectal fluids, and breast milk. For infection to occur, one of those fluids from a person with a detectable viral load must reach a mucous membrane, damaged tissue, or the bloodstream directly.

In practice that means anal or vaginal sex without a condom, sharing needles or other injecting equipment, and transmission from a parent to a baby during pregnancy, birth, or breastfeeding. Blood transfusions were once a route; screening of donated blood has made this vanishingly rare in the UK and other high-income countries, according to the NHS.

The virus does not survive well outside the body. Saliva, sweat, tears, and urine do not carry enough of it to cause infection. Kissing, sharing cutlery, hugging, toilet seats, swimming pools, and insect bites carry no risk at all, a point the CDC and NHS both state plainly.

Why does this matter for prevention? Because every effective strategy works by interrupting one specific link in that chain. A condom is a physical barrier. Clean needles remove the shared blood. Treatment removes the virus from the fluid. PrEP and PEP block the virus from establishing itself once it has arrived. Understanding the routes turns prevention from a vague worry into a set of concrete, checkable actions.

How common is HIV in the UK right now?

The short version: HIV in the UK is uncommon, well diagnosed, and largely controlled. The longer version needs some care with numbers.

The UK does not publish its figures through the international sources cited at the end of this article; they come from the annual national HIV surveillance report produced by the UK’s public health agency. Those reports estimate that a little over 100,000 people in the UK are living with HIV, a prevalence of roughly two people in every thousand adults. The great majority know their status, and of those diagnosed, almost all are on treatment with the virus suppressed. The UK has for several years met the WHO target of 95% diagnosed, 95% of those on treatment, and 95% of those suppressed.

New diagnoses each year number in the low thousands. A meaningful share of those are people diagnosed abroad who have moved to the UK and are already on treatment, so the figure for genuinely new infections is smaller than the headline number suggests. Heterosexual transmission now accounts for a growing proportion of new UK diagnoses; among gay and bisexual men, new infections fell sharply after 2015 as PrEP became widely available.

The government has set a target of ending new HIV transmissions within England by 2030. Whether that is reached depends less on new science than on reaching the people who are still being diagnosed late, often after years of undetected infection.

How does the UK picture compare with the rest of the world?

Globally, HIV remains one of the largest infectious disease burdens. The World Health Organization estimates that around 40 million people were living with HIV at the end of 2023, that roughly 1.3 million acquired it that year, and that about 630,000 died from HIV-related causes. Two-thirds of people living with HIV are in the WHO African Region.

Set against that, the UK’s two-in-a-thousand prevalence is low, and its treatment coverage is among the highest anywhere. The gap between the UK and hard-hit countries is not about biology. It is about access to testing, uninterrupted supply of medication, and the absence of laws or stigma that keep people away from clinics.

The global trend is encouraging even so. WHO reports that new infections have fallen substantially since 2010 and that about three-quarters of people living with HIV worldwide were receiving antiretroviral therapy in 2023. Deaths have more than halved since their peak.

One lesson travels well across borders. Every country that has driven infections down has done so by combining tools rather than betting on one. Condoms alone did not do it. Treatment alone did not do it. Testing, treatment, PrEP, harm reduction, and antenatal screening working together did. That combination approach is what the rest of this article describes.

What are the three pillars of HIV prevention?

People often search for the “three preventions” of HIV. Public health bodies frame it slightly differently, but the underlying logic reduces to three pillars that support everything else.

Know your status. Testing is the entry point. A person who does not know they have HIV cannot start treatment and cannot benefit from the fact that treatment stops transmission. In the UK, late diagnosis remains the single biggest weak spot in the system.

Treat everyone who has HIV. Antiretroviral therapy, started promptly and taken consistently, reduces the amount of virus in the blood until standard tests cannot detect it. At that level, WHO and the CDC agree, HIV is not transmitted through sex. Treatment is both a personal health measure and a public health one.

Protect people who do not have HIV. This is where condoms, PrEP, PEP, sterile injecting equipment, and safe infant feeding sit. Each addresses a different route or moment of risk.

The three pillars reinforce each other. A positive test leads to treatment, which removes onward transmission. A negative test in someone at ongoing risk opens the door to PrEP. A known exposure triggers PEP and a follow-up test. Remove any one pillar and the others carry more weight than they should.

If there is a single opinion worth holding about HIV prevention, it is this: testing is not the boring part. It is the part that makes the rest work.

Does HIV treatment really prevent transmission?

Yes. This is one of the most thoroughly tested claims in modern medicine and also one of the least understood by the public.

Antiretroviral therapy works by blocking the enzymes HIV needs to copy itself inside immune cells. With the virus unable to replicate, the amount circulating in blood and genital fluids falls, typically over a period of weeks to a few months, until it drops below the threshold that standard laboratory tests can measure. Clinicians call this an undetectable viral load.

Large international studies followed thousands of couples in which one partner had HIV and an undetectable viral load and the other did not, across many thousands of condomless sex acts. Not a single transmission from a partner with sustained undetectable levels was recorded. On that basis, the CDC states that people who take treatment as prescribed and keep an undetectable viral load have “effectively no risk” of passing HIV to a sexual partner. The campaign shorthand is U=U: undetectable equals untransmittable.

Three honest caveats. The protection depends on staying on treatment; viral load rebounds if medication stops. It applies to sexual transmission; evidence for breastfeeding shows very low but not zero risk. And it says nothing about other sexually transmitted infections, which treatment for HIV does not prevent.

For the person living with HIV, the same medication that protects their partner also protects their own immune system. The NHS notes that most people diagnosed today and started on treatment can expect a normal life expectancy.

What is PrEP and how does it work?

Pre-exposure prophylaxis, or PrEP, is medication taken by someone who does not have HIV to stop the virus from establishing an infection if they are exposed. It uses antiretroviral drugs from the same families used for treatment, present in the body before exposure rather than after.

The mechanism is straightforward. When HIV enters the body, it must infect a cell and copy its genetic material within the first hours to days. If the drug is already in the tissues at protective concentrations, that copying step fails and the infection never takes hold. Think of it as having the lock changed before the intruder arrives, rather than calling a locksmith afterwards.

The CDC summarizes the evidence this way: taken as prescribed, PrEP reduces the risk of acquiring HIV from sex by about 99% and from injection drug use by at least 74%. Effectiveness drops when doses are missed, which is why adherence support is part of every PrEP service.

PrEP is available in the UK through NHS sexual health clinics. It requires an HIV test before starting, to rule out an existing infection, and regular testing while on it, usually every three months, alongside kidney function checks and screening for other sexually transmitted infections. Daily and event-based schedules exist for different situations; a long-acting injectable form has also been developed. Which option suits a person, and how long protection takes to build after starting, are decisions for the prescribing clinician based on the type of exposure and the specific formulation.

PrEP does not protect against other infections and does not replace condoms for that purpose.

What to do after being exposed to HIV

If you think you have been exposed to HIV in the last three days, this is the section to act on now. Post-exposure prophylaxis, or PEP, is a course of antiretroviral medication started after a possible exposure to stop infection from establishing. The CDC and NHS are clear on the timing: PEP must begin within 72 hours, and the sooner the better. Every hour of delay gives the virus more opportunity to move from the site of exposure into the immune system.

In the UK, PEP is available from sexual health clinics and from emergency departments when clinics are closed. Both are free. A clinician will assess the type of exposure, whether the source person is known to have HIV and, if so, whether they are on treatment with an undetectable viral load, and will decide whether PEP is appropriate. Many reported exposures carry no real risk once assessed; the clinician will explain the reasoning either way.

The course typically lasts four weeks. Follow-up testing is arranged after it finishes, because PEP is highly effective but not guaranteed.

When to seek care urgently: go to a sexual health clinic or emergency department the same day if you have had condomless anal or vaginal sex with someone whose HIV status you do not know or who has untreated HIV, if a condom broke in that situation, if you have shared injecting equipment, or if you have experienced sexual assault. Do not wait for symptoms; there are none at the stage when PEP works. If more than 72 hours have passed, still attend. PEP will not be an option, but testing, support, and a conversation about PrEP will be.

Do condoms still matter now that PrEP and treatment exist?

They do, and for a reason that has nothing to do with HIV.

Condoms work as a physical barrier that stops semen, vaginal fluids, and blood from crossing between partners. Used consistently and correctly, they are highly effective against HIV, and the NHS lists them as a core prevention method. Their real-world effectiveness is lower than their theoretical effectiveness, because condoms slip, break, or go unused, which is exactly the gap that PrEP and treatment have closed.

What condoms offer that the pharmacological methods do not is protection against gonorrhea, chlamydia, syphilis, and other sexually transmitted infections. Rates of several of these have risen in the UK in recent years. A person on PrEP who stops using condoms is protected from HIV and exposed to everything else, which is why PrEP services test for other infections at every visit.

A few practical points make a difference. Water-based or silicone-based lubricant reduces friction and lowers the chance of breakage, especially for anal sex; oil-based products weaken latex. Condoms have expiry dates and should not be stored somewhere hot. A new condom is needed for each act of sex and each partner.

The honest framing is that condoms are no longer the only tool, and for many people they are no longer the main one. They remain the only single method that covers HIV and other infections at the same time, and the only one that requires no clinic, no prescription, and no blood test.

How does testing prevent HIV, and when is a test accurate?

Testing does not stop a virus entering a body. It stops a virus staying hidden. Roughly, the people who transmit HIV are the people who do not know they have it, because everyone who is diagnosed is offered treatment that removes the risk. That makes regular testing the quiet engine of prevention.

Timing matters because every test has a window period: the gap between infection and the point at which the test can reliably detect it. The CDC gives the following ranges.

Test type	What it detects	Window period after exposure
Nucleic acid test (NAT)	The virus itself	10 to 33 days
Antigen/antibody test, laboratory blood draw	Viral protein plus antibodies	18 to 45 days
Antigen/antibody rapid test, finger prick	Viral protein plus antibodies	18 to 90 days
Antibody test, including most self-tests	Antibodies only	23 to 90 days

A negative result inside the window period does not rule out infection; a repeat test after the window closes does. Clinics will advise the right interval based on the test used.

In the UK, testing is free at sexual health clinics and GP surgeries, home sampling kits can be ordered online in most areas, and emergency departments in higher-prevalence areas now test everyone having blood taken unless they opt out. The NHS recommends that anyone who has had condomless sex with a new partner, or who shares injecting equipment, tests regularly; sexually active gay and bisexual men are advised to test at least once a year, and more often with new partners.

How is HIV prevented in pregnancy and breastfeeding?

This is one of the clearest success stories in the whole field. Without any intervention, WHO estimates that between 15% and 45% of babies born to mothers with HIV acquire the virus during pregnancy, birth, or breastfeeding. With treatment and standard care, the NHS puts that risk below 1%.

The mechanism is the same one behind U=U. A pregnant person on antiretroviral therapy with an undetectable viral load has very little virus to pass across the placenta or during delivery. The remaining pieces of the strategy close the smaller gaps: the baby receives a short course of antiretroviral medication after birth, and the mode of delivery is planned according to the viral load near term.

In the UK, every pregnant person is offered an HIV test at their first antenatal appointment, which is why new diagnoses during pregnancy are picked up early and why transmission to babies is now rare. Declining the test is possible, but the NHS and WHO both recommend it as routine.

Feeding is the area where guidance is most nuanced. Formula feeding carries no HIV risk. Breastfeeding while on effective treatment carries a very low but not zero risk, and UK guidelines support people who choose to breastfeed to do so with close monitoring and support. The decision sits with the parent and their HIV and maternity teams together.

For anyone planning a pregnancy where one partner has HIV, the same principles apply. Undetectable viral load means conception can happen without transmission risk, and PrEP is an option for the partner without HIV if reassurance is wanted.

How is HIV prevented among people who inject drugs?

Sharing a needle or syringe is the most efficient way HIV moves between people, because it delivers blood directly into the bloodstream. It also carries hepatitis B and C, which are far more common in the UK than HIV among people who inject.

The evidence-based answer is harm reduction, and the UK has practiced it for longer than most countries. Needle and syringe programs provide sterile equipment free and without judgment; WHO lists them among the core interventions that have kept HIV rates among people who inject drugs low in countries that adopted them early. Opioid substitution treatment reduces injecting frequency and the pressure to share. PrEP is an option for people who continue to inject, with the CDC noting a reduction in risk of at least 74% when taken as prescribed.

The equipment that matters goes beyond the needle. Spoons, filters, water, and swabs can all carry blood. Sterile versions are available from the same services.

It is worth being clear that the low UK rate is not an accident of geography. Countries that closed or restricted needle programs have seen outbreaks. The lesson from decades of surveillance is that access to sterile equipment prevents infections, does not increase drug use, and costs a fraction of lifelong treatment. Anyone who injects and has shared equipment recently should seek PEP within 72 hours and a test, without expecting to be judged for asking.

What are five ways HIV can be prevented?

People searching for a simple list deserve one, with the reasoning attached. These five methods cover the routes of transmission described earlier, and they work best in combination.

• Use condoms for anal and vaginal sex. A barrier method that also protects against other sexually transmitted infections.
• Take PrEP if you are at ongoing risk. Medication present before exposure blocks the virus from establishing infection; about 99% risk reduction from sex when taken as prescribed, per the CDC.
• Start PEP within 72 hours of a possible exposure. Emergency medication taken for a short course after the event.
• Never share needles, syringes, or other injecting equipment. Sterile supplies are free from needle and syringe programs.
• Test regularly, and if you have HIV, take treatment. An undetectable viral load means the virus cannot be passed on through sex.

Two further measures matter in specific situations. Antenatal testing and treatment during pregnancy prevent transmission to babies. Voluntary medical male circumcision reduces female-to-male heterosexual transmission by around 60% according to WHO trial data, and is part of prevention programs in high-prevalence countries, though it is not a UK public health measure.

What is deliberately missing from the list is anything about lifestyle, character, or who a person is. HIV prevention is about actions and access, not identity. That shift in framing, away from “risk groups” toward specific behaviors and the tools that address them, is one of the reasons the UK’s numbers have moved in the right direction.

Is HIV curable now?

No. There is no cure for HIV, and anyone offering one is selling something. The NHS, WHO, and CDC are unanimous on this point.

What has changed is what “no cure” means in practice. HIV is now a manageable long-term condition. Treatment suppresses the virus, protects the immune system, prevents progression to AIDS, and stops sexual transmission. People diagnosed today and started on treatment promptly have a life expectancy close to that of the general population, according to the NHS.

The reason a cure remains out of reach is biological. HIV inserts its genetic code into long-lived immune cells, where it can sit dormant for years, invisible to both the immune system and current drugs. Stop treatment and those reservoir cells reactivate, usually within weeks. Every cure strategy under research, from gene editing to immune-based approaches, is trying to find and eliminate that reservoir.

A very small number of people have been reported free of HIV after receiving stem cell transplants for blood cancers, using donor cells carrying a rare genetic variant that resists the virus. These cases are scientifically important and medically irrelevant to almost everyone, because the transplant itself carries serious risk and is only justified by the cancer being treated.

The realistic hope is not a pill that erases the virus next year. It is the steady expansion of treatment and prevention that makes new infections rare and the existing ones harmless to health and to partners. That is not a cure, but for public health it achieves much of what a cure would.

Which HIV myths still get in the way of prevention?

Misinformation about HIV does real damage, because it steers attention toward things that carry no risk and away from the things that do. A few persistent examples deserve a direct answer.

You can tell if someone has HIV. You cannot. Most people with HIV have no symptoms for years, and the flu-like illness that some experience in the first weeks after infection is easily mistaken for anything else. Only a test tells.

HIV only affects gay men. In the UK, heterosexual contact now accounts for roughly half of new diagnoses. Globally, the majority of people living with HIV are heterosexual women and men.

Kissing, sharing food, mosquitoes, or toilet seats can spread it. None of these transmit HIV. The virus does not survive in saliva at infectious levels, does not survive on surfaces, and is not carried by insects, as the CDC and NHS both confirm.

A person on treatment is still a danger to partners. The reverse is true. Someone on treatment with an undetectable viral load is among the lowest-risk sexual partners anyone can have, because there is no measurable virus to transmit.

PrEP is only for people who are careless. PrEP is a medical tool, like a seatbelt. Its users are people who have assessed their situation honestly and acted on it.

Stigma keeps people from testing, and untested infections are the ones that spread. Correcting these myths is not a courtesy to people living with HIV. It is a prevention measure in its own right.

When should you see a doctor about HIV?

There are three moments when medical advice should not wait.

The first is after a possible exposure within the past 72 hours: condomless anal or vaginal sex with a partner of unknown or positive untreated status, a shared needle, or sexual assault. Go to a sexual health clinic or emergency department the same day for a PEP assessment. This is the one HIV situation where hours genuinely matter.

The second is the appearance of an illness that could be early HIV. Within two to six weeks of infection, the NHS notes, many people develop a short flu-like illness with fever, sore throat, a rash on the chest or back, swollen lymph nodes, and tiredness. These symptoms are common and usually caused by something else, but if they follow a possible exposure, a test is the only way to know. Do not rely on a negative test taken during the window period; repeat it as advised.

The third is ongoing risk without a plan. If you have new or multiple partners, if a partner has HIV and you are not sure of their viral load, or if you inject drugs, a sexual health clinic can arrange regular testing and discuss whether PrEP fits your situation.

Red flags that need prompt assessment regardless of HIV status include persistent unexplained fever, unexplained weight loss, recurrent infections, night sweats lasting more than a couple of weeks, or oral thrush in an adult. These can indicate a range of conditions, some serious, and deserve a proper work-up rather than online guesswork. A GP or sexual health service will know where to start, and HIV testing in the UK is free and confidential wherever you choose to have it.

Frequently asked questions

What are 5 ways HIV can be prevented?

The five core methods are using condoms for anal and vaginal sex, taking PrEP if you are at ongoing risk, starting PEP within 72 hours of a possible exposure, never sharing needles or injecting equipment, and testing regularly so that anyone with HIV can begin treatment. Treatment lowers the virus to undetectable levels, at which point it cannot be passed on sexually. Antenatal testing during pregnancy prevents transmission to babies.

Is HIV curable now?

No, HIV cannot currently be cured. Treatment can suppress the virus to undetectable levels, protect the immune system, and prevent transmission, and people diagnosed and treated promptly can expect a near-normal life expectancy according to the NHS. The virus hides in long-lived immune cells and returns if treatment stops. A handful of people have been reported free of HIV after stem cell transplants for cancer, but that procedure is far too risky to use for HIV alone.

What are the three preventions of HIV?

HIV prevention rests on three pillars: knowing your status through testing, treating everyone who has HIV so the virus becomes undetectable and untransmittable, and protecting people who do not have HIV with condoms, PrEP, PEP, sterile injecting equipment, and antenatal care. Each pillar supports the others. A test leads to treatment or to PrEP; a known exposure leads to PEP and follow-up testing.

What should you do after being exposed to HIV?

Go to a sexual health clinic or emergency department as soon as possible, ideally within hours and no later than 72 hours after the exposure, to be assessed for post-exposure prophylaxis (PEP). A clinician will judge whether the exposure carried real risk and prescribe a short course if it did. Testing is arranged after the course. If more than 72 hours have passed, still attend for testing and advice about PrEP.

How common is HIV in the UK?

National surveillance estimates that a little over 100,000 people in the UK are living with HIV, roughly two adults in every thousand. The great majority are diagnosed, on treatment, and have an undetectable viral load. New diagnoses number in the low thousands each year, and a growing share are through heterosexual contact. The UK government aims to end new HIV transmissions within England by 2030.

Can you get HIV from kissing or sharing food?

No. HIV is not present in saliva at infectious levels and does not survive on surfaces, cutlery, or in food. It is transmitted only through blood, semen, pre-seminal fluid, vaginal and rectal fluids, and breast milk reaching a mucous membrane, damaged tissue, or the bloodstream. Kissing, hugging, sharing drinks, toilet seats, swimming pools, and insect bites carry no risk, as the CDC and NHS both confirm.

How long after exposure can HIV be detected?

It depends on the test. According to the CDC, nucleic acid tests can detect HIV 10 to 33 days after exposure, laboratory antigen/antibody tests 18 to 45 days, rapid finger-prick antigen/antibody tests 18 to 90 days, and antibody-only tests, including most home self-tests, 23 to 90 days. A negative result inside the window period does not rule out infection, so clinics advise a repeat test once the window has closed.

Does PrEP protect against other sexually transmitted infections?

No. PrEP protects only against HIV. It offers no protection against gonorrhea, chlamydia, syphilis, herpes, or hepatitis, several of which have risen in the UK in recent years. Condoms remain the only single method that covers HIV and other infections together. This is why PrEP services test for other sexually transmitted infections at every routine visit, usually every three months.

Can someone with HIV have a baby without passing it on?

Yes. With treatment that keeps the viral load undetectable, planned delivery, and a short course of medication for the newborn, the NHS puts the risk of transmission to the baby below 1%. Without treatment, WHO estimates the risk at 15% to 45%. Every pregnant person in the UK is offered an HIV test at their first antenatal appointment. Feeding decisions are made with the HIV and maternity teams.

What are the early symptoms of HIV?

Within two to six weeks of infection, many people develop a short flu-like illness with fever, sore throat, a rash, swollen lymph nodes, tiredness, and sometimes joint pain, according to the NHS. It passes within a couple of weeks and is easily mistaken for a viral infection. After that, HIV can cause no symptoms for years while still damaging the immune system. Only a test can confirm or rule it out.

References

• World Health Organization – HIV and AIDS fact sheet
• NHS – HIV and AIDS
• CDC – Pre-Exposure Prophylaxis (PrEP)
• CDC – Post-Exposure Prophylaxis (PEP)

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.